XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.300
0.00 (0.00%)
Nov 12, 2026, 4:26 PM IST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 17.22 million as of November 12, 2026. It is the 44,430th most valuable company in the world and the 469th biggest in Israel. Its market cap has decreased by 42.54% in one year.
Market Cap
17.22M
Enterprise Value
16.98M
Revenue
n/a
Global Rank
Country Rank
#469 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 17.22M, a decrease of -97.86%. That is a compound annual growth rate of -16.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 17.22M | -24.18% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 184.57M |
| Matricelf | 79.42M |
| Clal Biotechnology Industries | 33.09M |
| Purple Biotech | 32.42M |
| BioLineRx | 29.87M |
| BioLight Life Sciences | 27.24M |
| Evogene | 18.35M |
| Can-Fite BioPharma | 15.16M |